| Disease | Target Count | P-value |
|---|---|---|
| lung carcinoma | 2843 | 1.3e-15 |
| psoriasis | 6694 | 6.0e-14 |
| cystic fibrosis | 1696 | 2.1e-05 |
| invasive ductal carcinoma | 2951 | 2.6e-03 |
| intraductal papillary-mucinous adenoma (IPMA) | 2955 | 8.9e-03 |
| group 3 medulloblastoma | 4104 | 9.1e-03 |
| astrocytic glioma | 2597 | 1.0e-02 |
| ductal carcinoma in situ | 1745 | 1.1e-02 |
| oligodendroglioma | 2850 | 1.7e-02 |
| ependymoma | 4679 | 2.1e-02 |
| Breast cancer | 3578 | 2.5e-02 |
| intraductal papillary-mucinous neoplasm (IPMN) | 3291 | 4.7e-02 |
| osteosarcoma | 7950 | 4.9e-02 |
| Disease | log2 FC | p |
|---|---|---|
| astrocytic glioma | -1.200 | 1.0e-02 |
| Breast cancer | 3.200 | 2.5e-02 |
| cystic fibrosis | -1.286 | 2.1e-05 |
| ductal carcinoma in situ | 1.200 | 1.1e-02 |
| ependymoma | -1.300 | 2.1e-02 |
| group 3 medulloblastoma | 1.700 | 9.1e-03 |
| intraductal papillary-mucinous adenoma (... | 2.500 | 8.9e-03 |
| intraductal papillary-mucinous neoplasm ... | 2.300 | 4.7e-02 |
| invasive ductal carcinoma | 1.100 | 2.6e-03 |
| lung carcinoma | -1.600 | 1.3e-15 |
| oligodendroglioma | -1.200 | 1.7e-02 |
| osteosarcoma | -1.792 | 4.9e-02 |
| psoriasis | 1.100 | 6.0e-14 |
MTLVLSMNRFCEPIVSEGAAEIAGYQTLWEADSYGGPSPPGPAQAPLQGDRGAGPPLAGSHYRGISNPIT 1 - 70 TSKITYFKRKYVEEEDFHPPLSSCSHKTISIFEERAHILYMSLEKLKFIDDPEVYLRRSVLINNLMKRIH 71 - 140 GEIIMQNNWCFPACSFNGTSAQEWFMAQDCPYRKRPRMAKEECEKFHACCFYQECGGHYLNLPLSVNANV 141 - 210 GSASTAASSPSASSSSSSSSSSPPLPLPSCSRQVDFDVGSASIYKSDGQIPANEIFVTNVRSLGVQEKAK 211 - 280 LNDEKANDDTNRDGGPLSHEPVGNDLAFECKGQFYDYFETGYNERNNVNESWKKSLRKKEASPPSNKLCC 281 - 350 SKGSKI 351 - 356 //
